In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that, Dr. Sanjeev Kumar Sharma, President - Manufacturing, Quality & R&D, designated as Senior Management Personnel (SMP) of the Company, has tendered his resignation from the services of the Company effective from close of business hours of 2nd February, 2026 due to personal reasons and consequently shall cease to be SMP of the Company.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Sanjeev Kumar Sharma, President – Manufacturing, Quality & R&D and designated Senior Management Personnel (SMP) of Wockhardt Limited, has resigned from the company. His resignation is effective from the close of business hours on 2nd February 2026. The reason cited is personal. Consequently, he will cease to be a Senior Management Personnel of the company. The company has informed the stock exchanges under SEBI Listing Regulations.
A senior-level exit in manufacturing, quality and R&D may raise short-term operational continuity concerns, though the stated reason is personal rather than performance-related. Investors should watch for the company's succession plan announcement to assess any impact on ongoing operations.